跳至主要内容
临床试验/CTRI/2022/09/045868
CTRI/2022/09/045868尚未招募4 期

A study of 3.75 CG prednisolone versus hydrocortisone, conventionaldose of prednisolone as replacement dose in adrenal insufficiency patients

Dr Priyadarshini Rajakumar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Diagnosed with adrenal insufficiency (AI) for over 6 months according to standard diagnostic
  • 2. Established on stable HC or prednisolone 5mg or more replacement, dose not altered for at
  • least 4 months
  • 3.Individuals taking other hormone replacements are accepted providing that their
  • replacement doses have not altered for at least 3 months;
  • 4. Individuals who are able and willing to give written informed consent to participate in the

排除标准

  • 1.Individuals who are unable to give informed consent
  • 2. Pregnancy (determined by patients self-reporting pregnancy status)
  • 3. Patients using the combined oral contraceptive pill

研究者

发起方
Dr Priyadarshini Rajakumar

相似试验